|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.430 USD | +2.14% |
|
-4.76% | -78.66% |
| 25-09-11 | GRI Bio Says Data Show No Lung Function Decline in Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis | MT |
| 25-04-01 | GRI Bio Prices up to $13 Million Equity Offering | MT |
| Market Cap | 5.39M 4.73M 4.41M 4.05M 7.6M 515M 7.73M 52.29M 20.47M 256M 20.25M 19.81M 883M | P/E 2021 |
-4.2x | P/E 2022 | -0.42x |
|---|---|---|---|---|---|
| Enterprise Value | 1.61M 1.41M 1.32M 1.21M 2.27M 154M 2.31M 15.63M 6.12M 76.37M 6.05M 5.92M 264M | EV / Sales 2021 |
-
| EV / Sales 2022 | - |
| Free-Float |
-
| Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | +2.14% | ||
| Current month | -78.66% | ||
| Current year | -78.66% |
| 5 years | 1.4 |  | 310.8 |
| 10 years | 1.4 | | 310.8 |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | - |
| Net income | -9.3M -8.16M -7.6M -6.99M -13.11M -889M -13.33M -90.2M -35.3M -441M -34.93M -34.17M -1.52B | -7.02M -6.16M -5.74M -5.28M -9.9M -671M -10.07M -68.1M -26.66M -333M -26.37M -25.8M -1.15B |
| Net Debt | -7.34M -6.44M -6M -5.52M -10.34M -701M -10.52M -71.17M -27.86M -348M -27.56M -26.96M -1.2B | -3.78M -3.32M -3.09M -2.84M -5.33M -361M -5.42M -36.66M -14.35M -179M -14.19M -13.89M -619M |
Employees
2
Sector
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-28 | US$1.430 | +2.14% | 19,736 |
| 26-07-27 | US$1.400 | -3.45% | 23,222 |
| 26-07-24 | US$1.450 | -3.33% | 29,826 |
| 26-07-23 | US$1.500 | +1.35% | 14,816 |
| 26-07-22 | US$1.480 | -1.99% | 23,352 |
- Stock Market
- Stocks
- GRI Stock
Select your edition
All financial news and data tailored to specific country editions
